Lifecore Biomedical

Yahoo Finance • 6 days ago

Stocks Supported by AI Spending Boom

The S&P 500 Index ($SPX) (SPY) today is up +0.40%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.84%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.07%.  December E-mini S&P futures (ESZ25) are up +0.37%, and December E-mini Nas... Full story

Yahoo Finance • 6 days ago

Stocks Climb on Rampant AI Optimism

The S&P 500 Index ($SPX) (SPY) today is up +0.29%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.45%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.18%.  December E-mini S&P futures (ESZ25) are up +0.27%, and December E-mini Nas... Full story

Yahoo Finance • 12 days ago

LIFECORE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In LifeCore (LFCR) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in LifeCore between October 7, 2... Full story

Yahoo Finance • 15 days ago

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

CHASKA, Minn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on September 22, 2025, the Life... Full story

Yahoo Finance • last month

Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference

CHASKA, Minn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate a... Full story

Yahoo Finance • last month

Lifecore granted Sector Weight rating at KeyBanc on growth trajectory

[Business on Wall Street in Manhattan] Pgiam/iStock via Getty Images KeyBanc Capital Markets has initiated the coverage of Lifecore Biomedical (NASDAQ:LFCR [https://seekingalpha.com/symbol/LFCR]) with a Sector Weight recommendation, notin... Full story

Yahoo Finance • last month

Lifecore Biomedical to Participate in Upcoming Investor Conferences

CHASKA, Minn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate i... Full story

Yahoo Finance • 2 months ago

Does LifeCore (LFCR) Have a High Expected Value?

Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. A copy of the letter can be downloaded here. In the second quarter, the fund returned... Full story

Yahoo Finance • 2 months ago

LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In LifeCore (LFCR) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in LifeCore between October 7, 2... Full story

Yahoo Finance • 2 months ago

Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update

-- Recorded $128.9 Million in Fiscal 2025 Revenue, Meeting Full-Year Guidance; Maintains Commitment to Mid-Term Outlook -- -- Nine New Programs Signed with New Customers During Fiscal 2025, Reflecting Growth into Modalities Beyond the Co... Full story

Yahoo Finance • 2 months ago

Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025

CHASKA, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial result... Full story

Yahoo Finance • 3 months ago

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CHASKA, Minn., July 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on July 11, 2025, the Lifecore c... Full story

Yahoo Finance • 4 months ago

Lifecore signs 10-year manufacturing deal with key ophthalmic client

CHASKA, Minn. - Lifecore Biomedical, Inc. (NASDAQ: LFCR), a $247 million market cap company with annual revenues of $130 million, has secured a new 10-year commercial manufacturing and supply agreement with an existing customer for an opht... Full story

Yahoo Finance • 4 months ago

Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer

CHASKA, Minn., June 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has signed a new 10-year com... Full story

Yahoo Finance • 4 months ago

Lifecore Biomedical Q3 2025 slides: Revenue dip amid ambitious growth strategy

Lifecore Biomedical Inc. (NASDAQ:LFCR) recently presented its corporate strategy and financial performance, highlighting its transformation into a specialized contract development and manufacturing organization (CDMO) focused on sterile in... Full story

Yahoo Finance • 4 months ago

Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale

CHASKA, Minn., June 12, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has received the remaining $... Full story

Yahoo Finance • 4 months ago

Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer

Mr. DaFonseca Possesses Nearly 30 Years of Broad Drug Development Experience, including More than 15 Years Leading High Performing CDMO Sales Organizations Will Leverage Deep Pharma Services Expertise as Leader of Lifecore’s Sales Organiz... Full story

Yahoo Finance • 5 months ago

What Makes Lifecore Biomedical (LFCR) a Beneficiary of the Trade Policies?

Greenhaven Road Capital, an investment management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, the fund returned around -12% net of fees and expenses, trailing... Full story

Yahoo Finance • 6 months ago

Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference

CHASKA, Minn., April 22, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate i... Full story

Yahoo Finance • 6 months ago

Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer

Mr. Salus Brings More than 30 Years of Broad-Based Legal and Management Expertise Highlighted by Extensive Experience within Life Sciences Industry Significantly Elevates Lifecore’s Capabilities Across Corporate Governance, Transactional... Full story